chronic lymphocytic leukemia

By DDNews Staff

GENUINE progress

TG Therapeutics' GENUINE trial shows that ublituximab plus ibrutinib improves survival in patients with chronic lymphocytic leukemia
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN Magazine May 2024

Latest Issue  

• Volume 20 • Issue 3 • May 2024

May 2024

May 2024 Issue